Find the best home for your research

With over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper.
Leider unterstützen wir Ihren Browser nicht vollständig. Wenn Sie die Möglichkeit dazu haben, nehmen Sie bitte ein Upgrade auf eine neuere Version vor oder verwenden Sie Mozilla Firefox, Microsoft Edge, Google Chrome oder Safari 14 bzw. eine neuere Version. Wenn Sie nicht dazu in der Lage sind und Unterstützung benötigen, senden Sie uns bitte Ihr Feedback.
Wir würden uns über Ihr Feedback zu diesen neuen Seiten freuen.Sagen Sie uns, was Sie denken
Welcome to the Elsevier exhibit landing page for CSCO 2025. Explore our latest offerings, including our leading oncology journals, the comprehensive ESMO journal portfolio, and a special prostate cancer article collection that is free to access until the end of December 2025. These resources are designed to strengthen your research and drive meaningful progress in cancer treatment and care.
With over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper.
Explore the cutting-edge research and clinical advancements in oncology with the Elsevier Oncology Journal Network catalogue, your gateway to the most comprehensive collection of oncology journals, including sample issues available to read.
Discover ESMO journals. Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
Open access is vital to a collaborative, inclusive and transparent world of research where quality knowledge can be shared and built upon. Every day, we work to bring more insight into closer reach for the research community and the public. We offer a wide choice and flexibility for every researcher and institution around the world that wants to publish open access, without ever compromising on research quality, integrity and value.